Curaleaf Holdings (CURLF) Net of Acquisitions & Divestments (2023 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Net of Acquisitions & Divestments of -$1000.0 for Q3 2024, up 99.97% year-on-year from -$500.09 in Q4 2023, and up 99.97% on a QoQ basis from -$2.9 million in Q3 2023.
Curaleaf Holdings (CURLF) Net of Acquisitions & Divestments (2023 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Net of Acquisitions & Divestments for 2 consecutive years, with -$1000.0 the latest figure, recorded in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 6.95 Bn | 6.95 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2023 | -2.93 Mn |
| Sep 30, 2023 | -2.93 Mn |